- Previous Close
4.4100 - Open
4.5200 - Bid 4.3000 x 100
- Ask 4.7400 x 100
- Day's Range
4.3400 - 4.6283 - 52 Week Range
3.6300 - 5.5000 - Volume
78,467 - Avg. Volume
232,223 - Market Cap (intraday)
83.597M - Beta (5Y Monthly) --
- PE Ratio (TTM)
55.62 - EPS (TTM)
0.0800 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Basel Medical Group Ltd engages in the provision of healthcare services in Singapore. The company offers general and subspecialized orthopedic, trauma, sports medicine, and neurosurgical services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures. Its services also include consultation, medical diagnosis, and medical and surgical treatments for orthopedic, trauma, sports medicine, and neurological conditions. The company was incorporated in 2023 and is based in Singapore.
baselmedical.comRecent News: BMGL
View MorePerformance Overview: BMGL
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BMGL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BMGL
View MoreValuation Measures
Market Cap
83.60M
Enterprise Value
85.37M
Trailing P/E
52.24
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.77
Price/Book (mrq)
14.58
Enterprise Value/Revenue
11.20
Enterprise Value/EBITDA
36.20
Financial Highlights
Profitability and Income Statement
Profit Margin
20.58%
Return on Assets (ttm)
8.44%
Return on Equity (ttm)
31.77%
Revenue (ttm)
10.07M
Net Income Avi to Common (ttm)
2.07M
Diluted EPS (ttm)
0.0800
Balance Sheet and Cash Flow
Total Cash (mrq)
2.04M
Total Debt/Equity (mrq)
75.55%
Levered Free Cash Flow (ttm)
1.43M